Clinical Trial Update: Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 open-label extension study of zilucoplan in generalized myasthenia gravis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Zilucoplan (zilucoplan)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: COMPLETED